Opus Genetics IRD Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's preferred stock, par or stated value per share?
- Opus Genetics (IRD) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has Opus Genetics's preferred stock, par or stated value per share changed year-over-year?
- Opus Genetics's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Opus Genetics's preferred stock, par or stated value per share?
- Over 5 years (2020 to 2025), Opus Genetics's preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.